CYP7A1 and metabolic dysfunction-associated steatotic liver disease: WANG et al. found that hyperosid elevates hepatic FXR/LXRα expression and CYP7A1 activity in rats, shifting bile acid composition toward conjugated forms to ameliorate NAFLD [108].